Insider Transactions in Q4 2022 at Maxcyte, Inc. (MXCT)
Insider Transaction List (Q4 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 05
2022
|
Thomas M. Ross EVP, GLOBAL SALES |
SELL
Open market or private sale
|
Direct |
14,133
-100.0%
|
$70,665
$5.59 P/Share
|
|
Dec 05
2022
|
Thomas M. Ross EVP, GLOBAL SALES |
BUY
Exercise of conversion of derivative security
|
Direct |
14,133
+50.0%
|
$14,133
$1.08 P/Share
|
|
Dec 02
2022
|
Thomas M. Ross EVP, GLOBAL SALES |
SELL
Open market or private sale
|
Direct |
15,000
-100.0%
|
$90,000
$6.02 P/Share
|
|
Dec 02
2022
|
Thomas M. Ross EVP, GLOBAL SALES |
BUY
Exercise of conversion of derivative security
|
Direct |
15,000
+50.0%
|
$15,000
$1.08 P/Share
|
|
Nov 02
2022
|
Thomas M. Ross EVP, GLOBAL SALES |
SELL
Open market or private sale
|
Direct |
5,704
-100.0%
|
$34,224
$6.85 P/Share
|
|
Nov 02
2022
|
Thomas M. Ross EVP, GLOBAL SALES |
BUY
Exercise of conversion of derivative security
|
Direct |
5,704
+34.08%
|
$0
$0.96 P/Share
|
|
Nov 01
2022
|
Thomas M. Ross EVP, GLOBAL SALES |
SELL
Open market or private sale
|
Direct |
23,429
-100.0%
|
$140,574
$6.94 P/Share
|
|
Nov 01
2022
|
Thomas M. Ross EVP, GLOBAL SALES |
BUY
Exercise of conversion of derivative security
|
Direct |
23,429
+50.0%
|
$0
$0.84 P/Share
|
|
Oct 11
2022
|
Thomas M. Ross EVP, GLOBAL SALES |
SELL
Open market or private sale
|
Direct |
4,282
-100.0%
|
$25,692
$6.51 P/Share
|
|
Oct 11
2022
|
Thomas M. Ross EVP, GLOBAL SALES |
BUY
Exercise of conversion of derivative security
|
Direct |
4,282
+50.0%
|
$0
$0.84 P/Share
|
|
Oct 10
2022
|
Thomas M. Ross EVP, GLOBAL SALES |
SELL
Open market or private sale
|
Direct |
24,851
-100.0%
|
$149,106
$6.45 P/Share
|
|
Oct 10
2022
|
Thomas M. Ross EVP, GLOBAL SALES |
BUY
Exercise of conversion of derivative security
|
Direct |
24,851
+50.0%
|
$0
$0.84 P/Share
|
|
Oct 03
2022
|
Casdin Partners Master Fund, L.P. > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
735,786
-6.85%
|
$4,414,716
$6.15 P/Share
|